The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bacteriophage Market Research Report 2025
Synopsis
The global market for Bacteriophage was valued at US$ 52.3 million in the year 2024 and is projected to reach a revised size of US$ 177 million by 2031, growing at a CAGR of 19.3% during the forecast period.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Global key players of bacteriophage include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., etc. The top three players hold a share about 34%. Europe is the largest market, has a share about 48%. In terms of product type, DsDNA Bacteriophage is the largest segment, occupied for a share of 91%. In terms of application, Animal Health has a share about 51 percent.
This report aims to provide a comprehensive presentation of the global market for Bacteriophage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophage.
The Bacteriophage market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bacteriophage market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacteriophage companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NPO Microgen
Qingdao Phagepharm Bio-tech
Armata Pharmaceuticals, Inc.
Phaxiam Therapeutics
Eliava BioPreparations
Intralytix
MicroMir
Phagelux
Pharmex Group, LLC
APS Biocontrol Ltd. (APS)
ACD Pharma
Proteon Pharmaceuticals
Micreos
Locus Biosciences, Inc
NexaBiome Limited
PhagePro
BiomX
INtODEWORLD, Inc.
TechnoPhage
Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bacteriophage company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Bacteriophage was valued at US$ 52.3 million in the year 2024 and is projected to reach a revised size of US$ 177 million by 2031, growing at a CAGR of 19.3% during the forecast period.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Global key players of bacteriophage include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., etc. The top three players hold a share about 34%. Europe is the largest market, has a share about 48%. In terms of product type, DsDNA Bacteriophage is the largest segment, occupied for a share of 91%. In terms of application, Animal Health has a share about 51 percent.
This report aims to provide a comprehensive presentation of the global market for Bacteriophage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophage.
The Bacteriophage market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bacteriophage market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacteriophage companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NPO Microgen
Qingdao Phagepharm Bio-tech
Armata Pharmaceuticals, Inc.
Phaxiam Therapeutics
Eliava BioPreparations
Intralytix
MicroMir
Phagelux
Pharmex Group, LLC
APS Biocontrol Ltd. (APS)
ACD Pharma
Proteon Pharmaceuticals
Micreos
Locus Biosciences, Inc
NexaBiome Limited
PhagePro
BiomX
INtODEWORLD, Inc.
TechnoPhage
Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bacteriophage company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bacteriophage Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 DsDNA Bacteriophage
1.2.3 SsDNA Bacteriophage
1.2.4 SsRNA Bacteriophage
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bacteriophage Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Animal Health
1.3.3 Aquaculture
1.3.4 Agriculture
1.3.5 Food Industry
1.3.6 Human Health
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bacteriophage Market Perspective (2020-2031)
2.2 Global Bacteriophage Growth Trends by Region
2.2.1 Global Bacteriophage Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bacteriophage Historic Market Size by Region (2020-2025)
2.2.3 Bacteriophage Forecasted Market Size by Region (2026-2031)
2.3 Bacteriophage Market Dynamics
2.3.1 Bacteriophage Industry Trends
2.3.2 Bacteriophage Market Drivers
2.3.3 Bacteriophage Market Challenges
2.3.4 Bacteriophage Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bacteriophage Players by Revenue
3.1.1 Global Top Bacteriophage Players by Revenue (2020-2025)
3.1.2 Global Bacteriophage Revenue Market Share by Players (2020-2025)
3.2 Global Bacteriophage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bacteriophage Revenue
3.4 Global Bacteriophage Market Concentration Ratio
3.4.1 Global Bacteriophage Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bacteriophage Revenue in 2024
3.5 Global Key Players of Bacteriophage Head office and Area Served
3.6 Global Key Players of Bacteriophage, Product and Application
3.7 Global Key Players of Bacteriophage, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bacteriophage Breakdown Data by Type
4.1 Global Bacteriophage Historic Market Size by Type (2020-2025)
4.2 Global Bacteriophage Forecasted Market Size by Type (2026-2031)
5 Bacteriophage Breakdown Data by Application
5.1 Global Bacteriophage Historic Market Size by Application (2020-2025)
5.2 Global Bacteriophage Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Bacteriophage Market Size (2020-2031)
6.2 North America Bacteriophage Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bacteriophage Market Size by Country (2020-2025)
6.4 North America Bacteriophage Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bacteriophage Market Size (2020-2031)
7.2 Europe Bacteriophage Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bacteriophage Market Size by Country (2020-2025)
7.4 Europe Bacteriophage Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bacteriophage Market Size (2020-2031)
8.2 Asia-Pacific Bacteriophage Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bacteriophage Market Size by Region (2020-2025)
8.4 Asia-Pacific Bacteriophage Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bacteriophage Market Size (2020-2031)
9.2 Latin America Bacteriophage Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Bacteriophage Market Size by Country (2020-2025)
9.4 Latin America Bacteriophage Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bacteriophage Market Size (2020-2031)
10.2 Middle East & Africa Bacteriophage Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bacteriophage Market Size by Country (2020-2025)
10.4 Middle East & Africa Bacteriophage Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NPO Microgen
11.1.1 NPO Microgen Company Details
11.1.2 NPO Microgen Business Overview
11.1.3 NPO Microgen Bacteriophage Introduction
11.1.4 NPO Microgen Revenue in Bacteriophage Business (2020-2025)
11.1.5 NPO Microgen Recent Development
11.2 Qingdao Phagepharm Bio-tech
11.2.1 Qingdao Phagepharm Bio-tech Company Details
11.2.2 Qingdao Phagepharm Bio-tech Business Overview
11.2.3 Qingdao Phagepharm Bio-tech Bacteriophage Introduction
11.2.4 Qingdao Phagepharm Bio-tech Revenue in Bacteriophage Business (2020-2025)
11.2.5 Qingdao Phagepharm Bio-tech Recent Development
11.3 Armata Pharmaceuticals, Inc.
11.3.1 Armata Pharmaceuticals, Inc. Company Details
11.3.2 Armata Pharmaceuticals, Inc. Business Overview
11.3.3 Armata Pharmaceuticals, Inc. Bacteriophage Introduction
11.3.4 Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Business (2020-2025)
11.3.5 Armata Pharmaceuticals, Inc. Recent Development
11.4 Phaxiam Therapeutics
11.4.1 Phaxiam Therapeutics Company Details
11.4.2 Phaxiam Therapeutics Business Overview
11.4.3 Phaxiam Therapeutics Bacteriophage Introduction
11.4.4 Phaxiam Therapeutics Revenue in Bacteriophage Business (2020-2025)
11.4.5 Phaxiam Therapeutics Recent Development
11.5 Eliava BioPreparations
11.5.1 Eliava BioPreparations Company Details
11.5.2 Eliava BioPreparations Business Overview
11.5.3 Eliava BioPreparations Bacteriophage Introduction
11.5.4 Eliava BioPreparations Revenue in Bacteriophage Business (2020-2025)
11.5.5 Eliava BioPreparations Recent Development
11.6 Intralytix
11.6.1 Intralytix Company Details
11.6.2 Intralytix Business Overview
11.6.3 Intralytix Bacteriophage Introduction
11.6.4 Intralytix Revenue in Bacteriophage Business (2020-2025)
11.6.5 Intralytix Recent Development
11.7 MicroMir
11.7.1 MicroMir Company Details
11.7.2 MicroMir Business Overview
11.7.3 MicroMir Bacteriophage Introduction
11.7.4 MicroMir Revenue in Bacteriophage Business (2020-2025)
11.7.5 MicroMir Recent Development
11.8 Phagelux
11.8.1 Phagelux Company Details
11.8.2 Phagelux Business Overview
11.8.3 Phagelux Bacteriophage Introduction
11.8.4 Phagelux Revenue in Bacteriophage Business (2020-2025)
11.8.5 Phagelux Recent Development
11.9 Pharmex Group, LLC
11.9.1 Pharmex Group, LLC Company Details
11.9.2 Pharmex Group, LLC Business Overview
11.9.3 Pharmex Group, LLC Bacteriophage Introduction
11.9.4 Pharmex Group, LLC Revenue in Bacteriophage Business (2020-2025)
11.9.5 Pharmex Group, LLC Recent Development
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Details
11.10.2 APS Biocontrol Ltd. (APS) Business Overview
11.10.3 APS Biocontrol Ltd. (APS) Bacteriophage Introduction
11.10.4 APS Biocontrol Ltd. (APS) Revenue in Bacteriophage Business (2020-2025)
11.10.5 APS Biocontrol Ltd. (APS) Recent Development
11.11 ACD Pharma
11.11.1 ACD Pharma Company Details
11.11.2 ACD Pharma Business Overview
11.11.3 ACD Pharma Bacteriophage Introduction
11.11.4 ACD Pharma Revenue in Bacteriophage Business (2020-2025)
11.11.5 ACD Pharma Recent Development
11.12 Proteon Pharmaceuticals
11.12.1 Proteon Pharmaceuticals Company Details
11.12.2 Proteon Pharmaceuticals Business Overview
11.12.3 Proteon Pharmaceuticals Bacteriophage Introduction
11.12.4 Proteon Pharmaceuticals Revenue in Bacteriophage Business (2020-2025)
11.12.5 Proteon Pharmaceuticals Recent Development
11.13 Micreos
11.13.1 Micreos Company Details
11.13.2 Micreos Business Overview
11.13.3 Micreos Bacteriophage Introduction
11.13.4 Micreos Revenue in Bacteriophage Business (2020-2025)
11.13.5 Micreos Recent Development
11.14 Locus Biosciences, Inc
11.14.1 Locus Biosciences, Inc Company Details
11.14.2 Locus Biosciences, Inc Business Overview
11.14.3 Locus Biosciences, Inc Bacteriophage Introduction
11.14.4 Locus Biosciences, Inc Revenue in Bacteriophage Business (2020-2025)
11.14.5 Locus Biosciences, Inc Recent Development
11.15 NexaBiome Limited
11.15.1 NexaBiome Limited Company Details
11.15.2 NexaBiome Limited Business Overview
11.15.3 NexaBiome Limited Bacteriophage Introduction
11.15.4 NexaBiome Limited Revenue in Bacteriophage Business (2020-2025)
11.15.5 NexaBiome Limited Recent Development
11.16 PhagePro
11.16.1 PhagePro Company Details
11.16.2 PhagePro Business Overview
11.16.3 PhagePro Bacteriophage Introduction
11.16.4 PhagePro Revenue in Bacteriophage Business (2020-2025)
11.16.5 PhagePro Recent Development
11.17 BiomX
11.17.1 BiomX Company Details
11.17.2 BiomX Business Overview
11.17.3 BiomX Bacteriophage Introduction
11.17.4 BiomX Revenue in Bacteriophage Business (2020-2025)
11.17.5 BiomX Recent Development
11.18 INtODEWORLD, Inc.
11.18.1 INtODEWORLD, Inc. Company Details
11.18.2 INtODEWORLD, Inc. Business Overview
11.18.3 INtODEWORLD, Inc. Bacteriophage Introduction
11.18.4 INtODEWORLD, Inc. Revenue in Bacteriophage Business (2020-2025)
11.18.5 INtODEWORLD, Inc. Recent Development
11.19 TechnoPhage
11.19.1 TechnoPhage Company Details
11.19.2 TechnoPhage Business Overview
11.19.3 TechnoPhage Bacteriophage Introduction
11.19.4 TechnoPhage Revenue in Bacteriophage Business (2020-2025)
11.19.5 TechnoPhage Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Bacteriophage Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of DsDNA Bacteriophage
Table 3. Key Players of SsDNA Bacteriophage
Table 4. Key Players of SsRNA Bacteriophage
Table 5. Key Players of Others
Table 6. Global Bacteriophage Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Bacteriophage Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Bacteriophage Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Bacteriophage Market Share by Region (2020-2025)
Table 10. Global Bacteriophage Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Bacteriophage Market Share by Region (2026-2031)
Table 12. Bacteriophage Market Trends
Table 13. Bacteriophage Market Drivers
Table 14. Bacteriophage Market Challenges
Table 15. Bacteriophage Market Restraints
Table 16. Global Bacteriophage Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Bacteriophage Market Share by Players (2020-2025)
Table 18. Global Top Bacteriophage Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage as of 2024)
Table 19. Ranking of Global Top Bacteriophage Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Bacteriophage Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Bacteriophage, Headquarters and Area Served
Table 22. Global Key Players of Bacteriophage, Product and Application
Table 23. Global Key Players of Bacteriophage, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bacteriophage Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Bacteriophage Revenue Market Share by Type (2020-2025)
Table 27. Global Bacteriophage Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Bacteriophage Revenue Market Share by Type (2026-2031)
Table 29. Global Bacteriophage Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Bacteriophage Revenue Market Share by Application (2020-2025)
Table 31. Global Bacteriophage Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Bacteriophage Revenue Market Share by Application (2026-2031)
Table 33. North America Bacteriophage Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Bacteriophage Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Bacteriophage Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Bacteriophage Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Bacteriophage Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Bacteriophage Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Bacteriophage Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Bacteriophage Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Bacteriophage Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Bacteriophage Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Bacteriophage Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Bacteriophage Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Bacteriophage Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Bacteriophage Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Bacteriophage Market Size by Country (2026-2031) & (US$ Million)
Table 48. NPO Microgen Company Details
Table 49. NPO Microgen Business Overview
Table 50. NPO Microgen Bacteriophage Product
Table 51. NPO Microgen Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 52. NPO Microgen Recent Development
Table 53. Qingdao Phagepharm Bio-tech Company Details
Table 54. Qingdao Phagepharm Bio-tech Business Overview
Table 55. Qingdao Phagepharm Bio-tech Bacteriophage Product
Table 56. Qingdao Phagepharm Bio-tech Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 57. Qingdao Phagepharm Bio-tech Recent Development
Table 58. Armata Pharmaceuticals, Inc. Company Details
Table 59. Armata Pharmaceuticals, Inc. Business Overview
Table 60. Armata Pharmaceuticals, Inc. Bacteriophage Product
Table 61. Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 62. Armata Pharmaceuticals, Inc. Recent Development
Table 63. Phaxiam Therapeutics Company Details
Table 64. Phaxiam Therapeutics Business Overview
Table 65. Phaxiam Therapeutics Bacteriophage Product
Table 66. Phaxiam Therapeutics Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 67. Phaxiam Therapeutics Recent Development
Table 68. Eliava BioPreparations Company Details
Table 69. Eliava BioPreparations Business Overview
Table 70. Eliava BioPreparations Bacteriophage Product
Table 71. Eliava BioPreparations Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 72. Eliava BioPreparations Recent Development
Table 73. Intralytix Company Details
Table 74. Intralytix Business Overview
Table 75. Intralytix Bacteriophage Product
Table 76. Intralytix Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 77. Intralytix Recent Development
Table 78. MicroMir Company Details
Table 79. MicroMir Business Overview
Table 80. MicroMir Bacteriophage Product
Table 81. MicroMir Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 82. MicroMir Recent Development
Table 83. Phagelux Company Details
Table 84. Phagelux Business Overview
Table 85. Phagelux Bacteriophage Product
Table 86. Phagelux Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 87. Phagelux Recent Development
Table 88. Pharmex Group, LLC Company Details
Table 89. Pharmex Group, LLC Business Overview
Table 90. Pharmex Group, LLC Bacteriophage Product
Table 91. Pharmex Group, LLC Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 92. Pharmex Group, LLC Recent Development
Table 93. APS Biocontrol Ltd. (APS) Company Details
Table 94. APS Biocontrol Ltd. (APS) Business Overview
Table 95. APS Biocontrol Ltd. (APS) Bacteriophage Product
Table 96. APS Biocontrol Ltd. (APS) Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 97. APS Biocontrol Ltd. (APS) Recent Development
Table 98. ACD Pharma Company Details
Table 99. ACD Pharma Business Overview
Table 100. ACD Pharma Bacteriophage Product
Table 101. ACD Pharma Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 102. ACD Pharma Recent Development
Table 103. Proteon Pharmaceuticals Company Details
Table 104. Proteon Pharmaceuticals Business Overview
Table 105. Proteon Pharmaceuticals Bacteriophage Product
Table 106. Proteon Pharmaceuticals Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 107. Proteon Pharmaceuticals Recent Development
Table 108. Micreos Company Details
Table 109. Micreos Business Overview
Table 110. Micreos Bacteriophage Product
Table 111. Micreos Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 112. Micreos Recent Development
Table 113. Locus Biosciences, Inc Company Details
Table 114. Locus Biosciences, Inc Business Overview
Table 115. Locus Biosciences, Inc Bacteriophage Product
Table 116. Locus Biosciences, Inc Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 117. Locus Biosciences, Inc Recent Development
Table 118. NexaBiome Limited Company Details
Table 119. NexaBiome Limited Business Overview
Table 120. NexaBiome Limited Bacteriophage Product
Table 121. NexaBiome Limited Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 122. NexaBiome Limited Recent Development
Table 123. PhagePro Company Details
Table 124. PhagePro Business Overview
Table 125. PhagePro Bacteriophage Product
Table 126. PhagePro Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 127. PhagePro Recent Development
Table 128. BiomX Company Details
Table 129. BiomX Business Overview
Table 130. BiomX Bacteriophage Product
Table 131. BiomX Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 132. BiomX Recent Development
Table 133. INtODEWORLD, Inc. Company Details
Table 134. INtODEWORLD, Inc. Business Overview
Table 135. INtODEWORLD, Inc. Bacteriophage Product
Table 136. INtODEWORLD, Inc. Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 137. INtODEWORLD, Inc. Recent Development
Table 138. TechnoPhage Company Details
Table 139. TechnoPhage Business Overview
Table 140. TechnoPhage Bacteriophage Product
Table 141. TechnoPhage Revenue in Bacteriophage Business (2020-2025) & (US$ Million)
Table 142. TechnoPhage Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Bacteriophage Picture
Figure 2. Global Bacteriophage Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Bacteriophage Market Share by Type: 2024 VS 2031
Figure 4. DsDNA Bacteriophage Features
Figure 5. SsDNA Bacteriophage Features
Figure 6. SsRNA Bacteriophage Features
Figure 7. Others Features
Figure 8. Global Bacteriophage Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Bacteriophage Market Share by Application: 2024 VS 2031
Figure 10. Animal Health Case Studies
Figure 11. Aquaculture Case Studies
Figure 12. Agriculture Case Studies
Figure 13. Food Industry Case Studies
Figure 14. Human Health Case Studies
Figure 15. Others Case Studies
Figure 16. Bacteriophage Report Years Considered
Figure 17. Global Bacteriophage Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Bacteriophage Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Bacteriophage Market Share by Region: 2024 VS 2031
Figure 20. Global Bacteriophage Market Share by Players in 2024
Figure 21. Global Top Bacteriophage Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Bacteriophage Revenue in 2024
Figure 23. North America Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Bacteriophage Market Share by Country (2020-2031)
Figure 25. United States Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Bacteriophage Market Share by Country (2020-2031)
Figure 29. Germany Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Bacteriophage Market Share by Region (2020-2031)
Figure 37. China Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Bacteriophage Market Share by Country (2020-2031)
Figure 45. Mexico Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Bacteriophage Market Share by Country (2020-2031)
Figure 49. Turkey Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Bacteriophage Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. NPO Microgen Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 53. Qingdao Phagepharm Bio-tech Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 54. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 55. Phaxiam Therapeutics Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 56. Eliava BioPreparations Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 57. Intralytix Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 58. MicroMir Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 59. Phagelux Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 60. Pharmex Group, LLC Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 61. APS Biocontrol Ltd. (APS) Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 62. ACD Pharma Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 63. Proteon Pharmaceuticals Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 64. Micreos Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 65. Locus Biosciences, Inc Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 66. NexaBiome Limited Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 67. PhagePro Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 68. BiomX Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 69. INtODEWORLD, Inc. Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 70. TechnoPhage Revenue Growth Rate in Bacteriophage Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
